4//SEC Filing
HACKMAN JEFFREY 4
Accession 0001104659-17-065277
CIK 0000827809other
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 5:46 PM ET
Size
9.5 KB
Accession
0001104659-17-065277
Insider Transaction Report
Form 4
HACKMAN JEFFREY
Exec. VP and COO
Transactions
- Award
Stock Option (Right to Buy)
2017-11-01+135,000→ 135,000 totalExercise: $4.71Exp: 2027-11-01→ Common Shares (135,000 underlying) - Award
Common Stock
2017-11-01+50,000→ 50,000 total - Award
Common Stock
2017-11-01+92,500→ 142,500 total
Footnotes (5)
- [F1]These shares are issuable pursuant to a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
- [F2]The restricted stock units vest in three equal annual installments beginning November 1, 2018.
- [F3]The restricted stock units vest in full on November 1, 2018.
- [F4]Each option has an exercise price equal to the closing price of a common share of the Issuer on the Nasdaq Global Select Market on the grant date.
- [F5]This stock option award will vest and become exercisable in three equal annual installments beginning November 1, 2018.
Documents
Issuer
NOVELION THERAPEUTICS INC.
CIK 0000827809
Entity typeother
Related Parties
1- filerCIK 0001721477
Filing Metadata
- Form type
- 4
- Filed
- Oct 31, 8:00 PM ET
- Accepted
- Nov 1, 5:46 PM ET
- Size
- 9.5 KB